Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Oncology 33

Oncology

MedTech News for Olympus and Fujifilm

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Olympus’s THUNDERBEAT Open Fine Jaw Type X Surgical Energy Device; Merit Medical’s TEMNO Elite; Thermo Fisher Scientific’s Oncomine Dx Target Test; Fujifilm Latest Generation Endoscopic Ultrasound; Indigo Diabetes’s Shine Clinical Trial; Cala Health Published Data for its TAPS Therapy

Olympus Launched THUNDERBEAT Open Fine Jaw Type X Surgical Energy Device On September 28, 2022, Olympus Corporation (Olympus), a global MedTech company, announced the release of the THUNDERBEAT™ Open Fine Jaw Type X surgical energy devices for open surgery. The device THUNDERBEAT Open Fine Jaw Type X surgical energy device is designed to support safer procedures. The device is already available commercially in Japan. The commercial launch of the product in Europe, the United States, and South Korea is expected in October 2022. The THUNDERBEATTM Open Fine Jaw Type X is a single-use hybrid ultrasonic and bipolar electrosurgical instrument des...

Explore More...

Pharma News

GBT, Syros; Takeda, Cevance collaborates; IND application to ZN-c3

pharma news

Wave Life Sciences stocks implode; Amarin’s VASCEPA approval; GSK seeks approval

Pharma News

Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

pharma news

Acquisition of ArQule; Synthorx; and Zentalis nabs a raise

Reblozyl under FDA review; Audentes buyout & Tecentriq’s new approval

Reblozyl under FDA review; Audentes buyout & Tecentriq’s new approval

Pharma News

Novartis buys Medicines; Blackstone Life Sciences and Ferring’s collaboration; Alexion’s Soliris (eculizumab) Approval;

Metastatic Pancreatic Cancer market

Metastatic Pancreatic Cancer Market Size: Emerging therapies, Unmet needs and Forecast analysis

Non-small cell lung cancer emerging therapies

Non-small cell lung cancer emerging therapies

Pharma News

AstraZeneca tops the first Pharma Invention Index; Amgen to buy 20.5% stake in a Chinese pharmaceutical, BeiGene; Ascentage, Henlius collaborates to develop a Combination therapy

Pharma News

AZ announces positive results for durvalumab and tremelimumab; FDA nods to extend LILETTA’s use to prevent pregnancy; Gilead, Glympse Bio teams up to advance NASH clinical development

$Refractory Metastatic Melanoma Market$

Refractory Metastatic Melanoma Market

metastatic breast cancer

Metastatic HER2-Positive Breast Cancer Infographic

pharma news

Rapt Therapeutics files IPO; Novartis stakes $80M for NASH

Human Epidermal Receptor 2 (HER2)/ HR2 positive negative Breast Cancer

New Therapeutic advances that have shifted the Breast cancer market scenario

Recent Pharma News

Roche’s Tecentriq combo proves effective in Bladder cancer

Pharma News

STipe raises USD 22M; FDA approves Darzalex for multiple myeloma

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly